Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Raman Spectroscopy Method Development – V 2.0

Posted on By

Analytical Method Development: SOP for Raman Spectroscopy Method Development – V 2.0

Standard Operating Procedure for Raman Spectroscopy Method Development in Pharmaceutical Analysis


Department Analytical Method Development
SOP No. SOP/AMD/177/2025
Supersedes SOP/AMD/177/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

To establish a standard procedure for the development and validation of Raman spectroscopy methods used in the identification, characterization, and quantification of pharmaceutical raw materials, intermediates, and finished products.

2.

Scope

This SOP is applicable to the Analytical Method Development (AMD) department for using Raman spectroscopy in routine identification testing, polymorph analysis, counterfeit detection, and process analytical technology (PAT) applications.

3. Responsibilities

  • Analytical Scientist: Develops method parameters, interprets spectral data, and validates method performance.
  • Instrument Analyst: Operates Raman spectrometer, performs system suitability, and manages raw data.
  • QA Officer: Reviews validation reports and ensures GMP compliance.
  • Head – AMD: Approves Raman methods and ensures regulatory alignment.

4. Accountability

The Head of Analytical Method Development is accountable for the scientific integrity, regulatory compliance, and approval of Raman spectroscopy methods used within the pharmaceutical facility.

5. Procedure

5.1 Instrument Setup and Calibration

  1. Calibrate the Raman spectrometer using certified standards such as polystyrene or silicon wafer (peak at 520.7 cm⁻¹).
  2. Check wavenumber accuracy and laser stability.
  3. Log calibration data in Annexure-1: Raman Calibration Log.

5.2 Sample Preparation

  1. No special preparation required for solids; powders can be analyzed directly.
  2. Liquids or gels can be analyzed using vials or immersion probes.
  3. Ensure sample is homogeneous and clean from dust or external contamination.

5.3 Method Parameters

  1. Excitation Wavelength: 785 nm (preferred), 532 nm or 1064 nm based on fluorescence profile.
  2. Laser Power: 10–100 mW, optimize to avoid sample degradation.
  3. Acquisition Time: 1–10 seconds per scan.
  4. Number of Scans: 3–10 accumulations for noise reduction.
  5. Spectral Range: 200–1800 cm⁻¹ typical (adjust based on compound).

5.4 Spectral Acquisition and Interpretation

  1. Collect spectra of reference standard, test sample, and blank.
  2. Process data using software with baseline correction, smoothing, and normalization.
  3. Compare test sample spectrum with library/reference using match score or overlay plots.
  4. Document peak positions and intensities in Annexure-2: Raman Spectral Log.

5.5 Method Validation

  1. Validate method according to ICH Q2(R2) and regulatory expectations:
    • Specificity: Distinguish target compound from structurally similar substances.
    • Precision: RSD ≤ 2% for peak intensity at key wavenumbers.
    • Accuracy: Compare with orthogonal method (e.g., IR, HPLC).
    • Robustness: Vary laser power and acquisition time.
    • LOD/LOQ: Based on signal-to-noise (S/N) criteria.
  2. Summarize findings in Annexure-3: Validation Summary.

5.6 Application Scenarios

  1. Polymorph screening during drug development.
  2. Raw material verification at warehouse stage.
  3. Monitoring blend uniformity in process development.
  4. Authentication of genuine vs. counterfeit products.

6. Abbreviations

  • Raman: Raman Spectroscopy
  • GMP: Good Manufacturing Practice
  • RSD: Relative Standard Deviation
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • SOP: Standard Operating Procedure

7. Documents

  1. Raman Calibration Log – Annexure-1
  2. Raman Spectral Log – Annexure-2
  3. Validation Summary – Annexure-3

8. References

  • ICH Q2(R2) – Validation of Analytical Procedures
  • USP <858> – Raman Spectroscopy
  • FDA Guidance on Process Analytical Technology (PAT)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Raman Calibration Log

Date Standard Used Theoretical Peak (cm⁻¹) Observed Peak (cm⁻¹) Deviation Analyst
18/05/2025 Silicon 520.7 520.6 –0.1 Rajesh Kumar

Annexure-2: Raman Spectral Log

Sample ID Major Peaks (cm⁻¹) Match Score (%) Comments Analyst
RM-API-010 641, 812, 1215 98.7% Confirmed identity Sunita Reddy

Annexure-3: Validation Summary

Parameter Result Acceptance Criteria Status
Precision RSD = 1.3% ≤ 2% Pass
Specificity No interference Distinct spectral peaks Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded validation parameters and updated application section Annual SOP Review
See also  Analytical Method Development: SOP for Handling Out of Trend (OOT) Results - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Change Control Management in Injectable Manufacturing – V 2.0
Next Post: Aerosol: SOP for Ensuring Proper Sealing in Aerosol Valves – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version